We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Gene Leap Led to Flea Transmission of Plague

By Biotechdaily staff writers
Posted on 24 May 2002
A single gene change in a relatively benign recent ancestor of the bacterium that causes bubonic plague played a key role in the evolution of the deadly disease, researchers
have discovered. More...
Their findings were reported in the April 25, 2002, issue of Science.

By acquiring this gene, the bacterium gradually changed from a germ that caused a mild human stomach illness acquired from contaminated food or water to the flea-borne agent of the Black Death, which in the 14th century killed one-fourth of Europe's population.

Our research illustrates how a single genetic change can profoundly affect the evolution of disease. In this case, that genetic change set the stage for a completely new route of
disease transmission, notes B. Joseph Hinnebusch, Ph.D., lead author of the study and plague expert at Rocky Mountain Laboratories, a Montana (USA) outpost of the US National Institute of Allergy and Infectious Diseases (NIAID).

The gene allowed the bacteria to be transmitted through the bite of an insect--in this case, the flea--an adaptation that distinguishes Yersinia pestis, the plague germ, from closely related, more benign gut bacteria. In turn, as Y pestis adapted to rely on its new blood-feeding host for transmission, the emergence of more deadly bacterial strains would have been favored, the researchers conclude.

In the report, Dr. Hinnebusch and colleagues from Sweden, Michigan, and NIAID describe how they explored the source of this gene. The gene codes for an enzyme known as PLD. Previous work indicated that Y pestis picked up this gene from either an unrelated bacterium or a simple nucleated organism. The researchers infected fleas with variants of Y pestis that either contained or lacked the PLD gene and then observed the outcome. They discovered that the enzyme is required for survival of the plague bacterium in the midgut of the rat flea. Although the enzyme's activity protects Y pestis from being destroyed, the researchers do not yet know the molecular mechanism by which this protection occurs. To find that out is clearly the next step, Dr. Hinnebusch notes.
.

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.